1. Diagnosis and treatment of cancer: A large number of studies have shown that the distribution and content of Fibronectin in vivo is closely related to the occurrence and development of tumors. At present, the relationship between Fibronectin and tumor has become more and more well known, and its research is also deepening. Developing Fibronectin products for tumor diagnosis and treatment will be a very valuable project.
2, treatment of the blood system and cardiovascular and cerebrovascular diseases: experimental evidence: the blood of patients with EDS supplemented with Fibronectin, can achieve platelet aggregation, relieve the disease. Atherosclerosis is a disease that generally harms the health of the elderly. Fibronectin has been shown to be involved in this process. Fibronectin content decreased with increasing degree of hardening of the arteries. The lack of plasma Fibronectin can cause the destruction of microvascular integrity and the increase of permeability, leading to massive extravasation of plasma, concentration of blood, increased viscosity, reduced circulating blood volume, imbalance of plasma and intracellular fluid balance, and dangerous conditions such as shock in the body.
Fibronectin can be used to treat cancer and cardiovascular and cerebrovascular diseases
